Literature DB >> 22962980

Assessing the influence of actinic keratosis on patients' quality of life: the AKQoL questionnaire.

S Esmann1, G R Vinding, K B Christensen, G B E Jemec.   

Abstract

BACKGROUND: Limited knowledge is available regarding quality of life in patients with actinic keratosis (AK).
OBJECTIVES: To develop and validate a disease-specific questionnaire - the Actinic Keratosis Quality of Life questionnaire (AKQoL) - to assess the quality of life of patients with AK.
METHODS: Based on an extensive literature search and patient interviews, the AKQoL was developed in a stepwise approach. An initial mega-questionnaire was composed and subsequently shortened based on statistical differences between patients and controls. A test-retest was done to establish the reliability and to refine the items further. Rasch analyses were performed on the final questionnaire.
RESULTS: Initially, 175 items were tested in a mega-questionnaire. The questionnaires were sent out twice and statistical analyses were made, reducing the number of questions to 18 and 10, respectively. Subsequent inter-item correlations showed that one item had only a weak correlation to the rest of the scale. This was confirmed by the Rasch model and by internal consistency as evaluated by Cronbach's coefficient alpha. Only one item was found to provide a small sex difference. A Bland-Altman plot showed excellent reliability. Items are scored on a standard 4-point Likert scale and summarized in a total score of maximum 27 points. A higher score indicates greater quality of life impairment.
CONCLUSIONS: A nine-item questionnaire for patients with AK was developed. The AKQoL has three domains covering emotions, function and control and one single global item. The questionnaire's scale structure, the content and face validity, and the reliability have been established.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2013        PMID: 22962980     DOI: 10.1111/bjd.12036

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Cultural adaptation and validation of the quality of life questionnaire for patients with actinic keratosis (AKQoL-BR) to Brazilian Portuguese.

Authors:  Marcella Akemi Haruno de Vilhena; Ivanka Miranda de Castro; Anna Carolina Miola; Ingrid Stresser Gioppo; Amanda Soares Teixeira; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-09-20       Impact factor: 2.113

2.  Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.

Authors:  Brian Berman; Stephen Tyring; Walter K Nahm; Marie Louise Østerdal; Astrid H Petersen; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

3.  Validity and Reliability of the Dutch Adaptation of the Actinic Keratosis Quality of Life Questionnaire (AKQoL).

Authors:  Kelly Vis; Rick Waalboer-Spuij; Dyon G C T M Snels; Loes M Hollestein
Journal:  Dermatology       Date:  2018-06-15       Impact factor: 5.366

Review 4.  Patient satisfaction and reported outcomes on the management of actinic keratosis.

Authors:  Raveena Khanna; Anshika Bakshi; Yasmin Amir; Gary Goldenberg
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-05-17

Review 5.  Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.

Authors:  Ayman Grada; Steven R Feldman; Nicola Luigi Bragazzi; Giovanni Damiani
Journal:  Dermatol Ther       Date:  2021-02-21       Impact factor: 2.851

6.  Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in Denmark.

Authors:  Gunnel Ragnarson Tennvall; J M Norlin; I Malmberg; A M Erlendsson; M Hædersdal
Journal:  Health Qual Life Outcomes       Date:  2015-07-29       Impact factor: 3.186

7.  Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study.

Authors:  Joanna Emilio; Michelle Schwartz; Eleanor Feldman; Amy Kalowitz Bieber; Amanda Bienenfeld; Min-Kyung Jung; Daniel M Siegel; Orit Markowitz
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-04-20

8.  Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.

Authors:  Steffen Emmert; Holger A Haenssle; John R Zibert; Margarete Schön; Andreas Hald; Maria H Hansen; Thomas Litman; Michael P Schön
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

9.  Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.

Authors:  W G Philipp-Dormston; K Müller; B Novak; K Strömer; C Termeer; U Hammann; J W Glutsch; G Krähn-Senftleben; H Lübbert; M Koller; R M Szeimies
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-12       Impact factor: 6.166

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.